Jeffrey A. Wald
Micropharma (Canada)(CA)
Publications by Year
Research Areas
Diabetes Treatment and Management, Hormonal and reproductive studies, Asthma and respiratory diseases, Diabetes Management and Research, Estrogen and related hormone effects
Most-Cited Works
- → GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models(2007)300 cited
- → Premenstrual Affective Syndrome and Affective Disorder(1975)102 cited
- → Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release(2015)101 cited
- → Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex‐specific competition in sports, a narrative review(2018)101 cited
- → An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma(1986)63 cited
- → Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man(1992)63 cited
- → Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women(2017)62 cited
- → Endogenous nitric oxide in expired air: Effects of acute exercise in humans(1994)60 cited
- → Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics(1991)45 cited
- → Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 AM versus 4 PM(1992)42 cited